Spire Wealth Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Spire Wealth Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$10K	–	2628
2022 Q4	$10K	Hold	500	–	–	﹤0.01%	1637
2022 Q3	$5K	Hold	500	–	–	﹤0.01%	1767
2022 Q2	$6K	Hold	500	–	–	﹤0.01%	2105
2022 Q1	$11K	Hold	500	–	–	﹤0.01%	2017
2021 Q4	$17K	Hold	500	–	–	﹤0.01%	2189
2021 Q3	$13K	Hold	500	–	–	﹤0.01%	2022
2021 Q2	$7K	Hold	500	–	–	﹤0.01%	2253
2021 Q1	$5K	Buy	+500	New	+$5.7K	﹤0.01%	2661

Spire Wealth Management's OPNT Position: Q1 2023 in Review

Spire Wealth Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 500 shares — an estimated $10K sold.

Spire Wealth Management first reported a position in OPNT in Q1 2021 and held it in 8 quarters. The position peaked at $17K in Q4 2021. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Spire Wealth Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Spire Wealth Management sold 500 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $10K.
Spire Wealth Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Spire Wealth Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $17K in Q4 2021.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Spire Wealth Management's 13F filing for Q1 2023, filed 9 May 2023.